Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer

Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer

Abstract Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of which more than 65% cases are diagnosed in advanced stages, requiring platinum-based neoadjuvant chemotherapy (NACT). Methods A prospective-longitudinal study was conducted among women with advanced epithe...

Full description

Bibliographic Details
Main Authors: Jorge A. Alegría-Baños, José C. Jiménez-López, Arely Vergara-Castañeda, David F. Cantú de León, Alejandro Mohar-Betancourt, Delia Pérez-Montiel, Gisela Sánchez-Domínguez, Mariana García-Villarejo, César Olivares-Pérez, Ángel Hernández-Constantino, Acitlalin González-Santiago, Miguel Clara-Altamirano, Liz Arela-Quispe, Diddier Prada-Ortega
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Journal of Ovarian Research
Subjects:
Biomarkers kinetic
HE4
CA125
Gynecological cancer
Ovarian cancer
Neoadjuvant chemotherapy
Online Access:https://doi.org/10.1186/s13048-021-00845-6

Internet

https://doi.org/10.1186/s13048-021-00845-6

Similar Items